chartexchange

BCLI
BRAINSTORM CELL THERAPUTC
stockOTC

EODNov 16, 2026
0.95USD-4.040%(-0.04)6,347
Loading…
Loading…
Healthcare
Biotechnology
CEO
Chaim Lebovits
HQ
New York, NY, USA
Previous Close
$0.99
Beta
0.05
52-Week High
$1.69 2026-07-06
52-Week Low
$0.46 2026-02-13
SMA 50
$0.91
SMA 200
$0.86
Avg. Vol 10D
22,855
Avg. Vol 30D
16,464
Avg. Vol 90D
21,482
Relative Vol
0.39
7.78M
4,962
Oct 1, 2024 · 1-for-15 (reverse)
BCLI Profile

brainstorm cell therapeutics inc. (nasdaq:bcli), is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders such as als (lou gehrig's disease), multiple sclerosis (ms) and parkinson's disease (pd). these diseases have limited treatment options and as such represent unmet medical needs. nurown™ is brainstorm's proprietary process for the propagation and differentiation of adult, autologous mesenchymal stem cells (msc) into neurotrophic factor (ntf)-secreting cells, and the transplantation of these specialized cells at or near the affected tissue site. our platform technology essentially converts mscs into living drug delivery system for ntfs. we have obtained proof-of-concept in a variety of animal models of neurodegenerative diseases, including parkinson's, huntington's, als, ms, and peripheral nerve injury. we have completed two single-arm clinical trials in als patients, conducted in israel, which have demonstr

BCLI Performance
PeriodPriceDateChangeBeta
1W0.972026-11-10-2.35%1.775
1M0.782026-10-16+21.94%-0.117
3M1.092026-08-17-12.47%-0.307
6M0.692026-05-18+37.68%-0.610
1Y0.682025-11-17+39.71%0.050
2Y1.222024-11-18-22.13%—
5Y48.752021-11-17-98.05%0.385
BCLI Stock Summary

BRAINSTORM CELL THERAPUTC (OTC:BCLI) stock price today is $0.95, and today's volume is 6,347. BCLI is down 4.040% today. The 30 day average volume is 16,464. BCLI market cap is $9.35M with 9.84M shares outstanding.